This patent addresses producing and using baicalin-loaded folic acid coupling albumin nanoparticles. This increases baicalin’s biological availability and nanoparticles’ tumor targeting and anticancer activity. Nanoparticles have several uses, including making BC drugs, and are non-toxic. The gene discussed is ALB; the disease is breast cancer.